Diabetic Sarcopenia. A proposed muscle screening protocol in people with diabetes

Producción Científica

Detalles Bibliográficos
Autores: Luis Román, Daniel Antonio de, García Almeida, José Manuel, Garrachón Vallo, Fernando, Guzmán Rolo, Germán, López Gómez, Juan José, Tarazona Santabalbina, Francisco José, Sanz París, Alejandro
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2024
País:España
Institución:Universidad de Valladolid
Repositorio:UVaDOC. Repositorio Documental de la Universidad de Valladolid
OAI Identifier:oai:uvadoc.uva.es:10324/73685
Acceso en línea:https://doi.org/10.1007/s11154-023-09871-9
https://uvadoc.uva.es/handle/10324/73685
Access Level:acceso abierto
Palabra clave:Muscle mass
Type 2 diabetes
Screening
Diagnosis
Sarcopenia
Malnutrition
HMB
id ES_0fe4cf8f937789711ffbfd0e2e53bfe7
oai_identifier_str oai:uvadoc.uva.es:10324/73685
network_acronym_str ES
network_name_str España
repository_id_str
spelling Diabetic Sarcopenia. A proposed muscle screening protocol in people with diabetesLuis Román, Daniel Antonio deGarcía Almeida, José ManuelGarrachón Vallo, FernandoGuzmán Rolo, GermánLópez Gómez, Juan JoséTarazona Santabalbina, Francisco JoséSanz París, AlejandroMuscle massType 2 diabetesScreeningDiagnosisSarcopeniaMalnutritionHMBProducción CientíficaObjectives To propose the grounds for “diabetic sarcopenia” as a new comorbidity of diabetes, and to establish a muscle screening algorithm proposal to facilitate its diagnosis and staging in clinical practice. Method: A qualitative expert opinion study was carried out using the nominal technique. A literature search was performed with the terms “screening” or “diagnostic criteria” and “muscle loss” or “sarcopenia” and “diabetes” that was sent to a multidisciplinary group of 7 experts who, in a face-to-face meeting, discussed various aspects of the screening algorithm. Results: The hallmark of diabetic sarcopenia (DS) is muscle mass atrophy characteristic of people with diabetes mellitus (DM) in contrast to the histological and physiological normality of muscle mass. The target population to be screened was defined as patients with DM with a SARC-F questionnaire > 4, glycosylated haemoglobin (HbA1C) ≥ 8.0%, more than 5 years since onset of DM, taking sulfonylureas, glinides and sodium/glucose cotransporter inhibitors (SGLT2), as well as presence of chronic complications of diabetes or clinical suspicion of sarcopenia. Diagnosis was based on the presence of criteria of low muscle strength (probable sarcopenia) and low muscle mass (confirmed sarcopenia) using methods available in any clinical consultation room, such as dynamometry, the chair stand test, and Body Mass Index (BMI)-adjusted calf circumference. DS was classified into 4 stages: Stage I corresponds to sarcopenic patients with no other diabetes complication, and Stage II corresponds to patients with some type of involvement. Within Stage II are three sublevels (a, b and c). Stage IIa refers to individuals with sarcopenic diabetes and some diabetes-specific impairment, IIb to sarcopenia with functional impairment, and IIc to sarcopenia with diabetes complications and changes in function measured using standard tests Conclusion: Diabetic sarcopenia has a significant impact on function and quality of life in people with type 2 diabetes mellitus (T2DM), and it is important to give it the same attention as all other traditionally described complications of T2DM. This document aims to establish the foundation for protocolising the screening and diagnosis of diabetic sarcopenia in a manner that is simple and accessible for all levels of healthcare.Springer2024info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://doi.org/10.1007/s11154-023-09871-9https://uvadoc.uva.es/handle/10324/73685reponame:UVaDOC. Repositorio Documental de la Universidad de Valladolidinstname:Universidad de ValladolidIngléshttps://link.springer.com/article/10.1007/s11154-023-09871-9info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by/4.0/oai:uvadoc.uva.es:10324/736852026-06-13T12:44:47Z
dc.title.none.fl_str_mv Diabetic Sarcopenia. A proposed muscle screening protocol in people with diabetes
title Diabetic Sarcopenia. A proposed muscle screening protocol in people with diabetes
spellingShingle Diabetic Sarcopenia. A proposed muscle screening protocol in people with diabetes
Luis Román, Daniel Antonio de
Muscle mass
Type 2 diabetes
Screening
Diagnosis
Sarcopenia
Malnutrition
HMB
title_short Diabetic Sarcopenia. A proposed muscle screening protocol in people with diabetes
title_full Diabetic Sarcopenia. A proposed muscle screening protocol in people with diabetes
title_fullStr Diabetic Sarcopenia. A proposed muscle screening protocol in people with diabetes
title_full_unstemmed Diabetic Sarcopenia. A proposed muscle screening protocol in people with diabetes
title_sort Diabetic Sarcopenia. A proposed muscle screening protocol in people with diabetes
dc.creator.none.fl_str_mv Luis Román, Daniel Antonio de
García Almeida, José Manuel
Garrachón Vallo, Fernando
Guzmán Rolo, Germán
López Gómez, Juan José
Tarazona Santabalbina, Francisco José
Sanz París, Alejandro
author Luis Román, Daniel Antonio de
author_facet Luis Román, Daniel Antonio de
García Almeida, José Manuel
Garrachón Vallo, Fernando
Guzmán Rolo, Germán
López Gómez, Juan José
Tarazona Santabalbina, Francisco José
Sanz París, Alejandro
author_role author
author2 García Almeida, José Manuel
Garrachón Vallo, Fernando
Guzmán Rolo, Germán
López Gómez, Juan José
Tarazona Santabalbina, Francisco José
Sanz París, Alejandro
author2_role author
author
author
author
author
author
dc.subject.none.fl_str_mv Muscle mass
Type 2 diabetes
Screening
Diagnosis
Sarcopenia
Malnutrition
HMB
topic Muscle mass
Type 2 diabetes
Screening
Diagnosis
Sarcopenia
Malnutrition
HMB
description Producción Científica
publishDate 2024
dc.date.none.fl_str_mv 2024
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://doi.org/10.1007/s11154-023-09871-9
https://uvadoc.uva.es/handle/10324/73685
url https://doi.org/10.1007/s11154-023-09871-9
https://uvadoc.uva.es/handle/10324/73685
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.relation.none.fl_str_mv https://link.springer.com/article/10.1007/s11154-023-09871-9
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by/4.0/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by/4.0/
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Springer
publisher.none.fl_str_mv Springer
dc.source.none.fl_str_mv reponame:UVaDOC. Repositorio Documental de la Universidad de Valladolid
instname:Universidad de Valladolid
instname_str Universidad de Valladolid
reponame_str UVaDOC. Repositorio Documental de la Universidad de Valladolid
collection UVaDOC. Repositorio Documental de la Universidad de Valladolid
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869403479673405440
score 15.812429

Similares en LA Referencia